Discovering the Origin of Vascular Aging Amyloid Protein Medin
Discovering the Origin of Vascular Aging Amyloid Protein Medin
批准号:
10351895
负责人:
Ming Li
金额:
$34.74万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-01 至 2024-04-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAmino AcidsAmyloidAmyloid ProteinsAmyloid beta-ProteinAmyloidosisAortic AneurysmAortic DiseasesAutomobile DrivingBiochemistryBioinformaticsBiologicalBiological ProcessBiologyBlood VesselsCRISPR/Cas technologyCandidate Disease GeneCardiovascular DiseasesCell surfaceCellsCerebrovascular DisordersClustered Regularly Interspaced Short Palindromic RepeatsDementiaDiabetes MellitusDiseaseEGF geneEndothelial CellsEndotheliumEnzymesEpitopesExposure toFunctional disorderGene ProteinsGene TargetingGenerationsGenesGenomicsGoalsHumanHyperlipidemiaHypertensionImpairmentIndividualInflammatoryInvestigationKnock-outKnowledgeLeadMeasuresMetabolismMilk ProteinsMolecularMolecular BiologyMolecular ConformationMorbidity - disease rateMusMyocardial InfarctionOutcome StudyParentsPathologyPeptide HydrolasesPeptidesPhenotypeProcessProductionProtein ConformationProteinsProteolysisReporterResearchRiskRisk FactorsSiteSmokingStrokeStructural ModelsSystemVascular Dementiaage relatedagedamyloid formationbioinformatics toolcandidate validationcardiometabolic riskcardiovascular risk factorcerebrovascularendothelial dysfunctionfunctional genomicsgenome-widegenomic toolshuman diseasein silicoknock-downmedinmilk fat globulemilk productionmolecular dynamicsmortalitynoveloverexpressionpreservationscreening
中文摘要
摘要
年龄是心血管和脑血管疾病(CVD)最重要的危险因素,
是美国和世界范围内死亡和发病的主要原因。衰老导致血管损伤
独立于传统的心脏代谢危险因素,同时放大后者的损害。Medin是一个
50-来源于其母体蛋白乳脂肪球-EGF因子8蛋白的氨基酸淀粉样前体
(MFGE8)。随着年龄的增长,它在血管系统中积累,并导致人类最常见的形式
淀粉样变性Medin与血管老化、主动脉疾病、阿尔茨海默病和血管疾病有关。
痴呆关于medin产生的机制知之甚少,我们也不知道medin是什么。
负责MFGE 8切割的蛋白酶。该提案的主要目标是解决这一重大问题,
通过使用新的基因组学和生物信息学工具缩小知识差距。在目标1中,我们将在人类中开发
内皮细胞的MFGE 8加工活性的可靠和定量报告系统,并使用它
作为可选择的表型,进行全基因组CRISPR/Cas9敲除筛选,
直接或间接参与medin生成,但特别关注蛋白酶的基因。在
目的2,我们将进行计算机分子动力学研究,以了解MFGE 8构象变化
需要暴露medin切割位点,并根据目标1中确定的基因靶点,通过计算机模拟使用
蛋白质生物信息学来选择在结构上预测与MFGE 8相互作用的潜在蛋白酶,
合适的构造。在目标3中,我们将功能性地询问来自目标的候选基因/蛋白质
1和2通过在报告内皮细胞和幼稚内皮细胞中过表达或单独敲除它们来表达。
内皮细胞,以评估medin生成的预测变化并确认其生物学相关性。
确定酶,蛋白质和分子结构决定因素的medin产生是一个关键步骤,
了解和逆转medin的病理生理学,这将有助于解决血管老化,
血管性痴呆、AD和主动脉疾病。
英文摘要
ABSTRACT
Age is the most important risk factor for cardiovascular and cerebrovascular diseases (CVD), the
leading causes of mortality and morbidity in the US and worldwide. Aging causes vascular impairment
independent of the traditional cardiometabolic risk factors, while magnifying the latter’s damage. Medin is a
50-amino acid amyloid precursor derived from its parent protein milk fat globule-EGF factor 8 protein
(MFGE8). It accumulates in the vasculature with aging and contributes to the most common form of human
amyloidosis. Medin is implicated in vascular aging, aortic disease, Alzheimer’s disease and vascular
dementia. Little is known as to the mechanism by which medin is generated and we do not know the
protease(s) responsible for MFGE8 cleavage. The main goal of the proposal is to address this major
knowledge gap through use of novel genomic and bioinformatics tools. In Aim 1, we will develop in human
endothelial cells a reliable and quantitative reporter system for the processing activity for MFGE8, and use it
as a selectable phenotype to conduct genome wide CRISPR/Cas9 knockout screening to identify genes
involved in medin generation either directly or indirectly, but with particular focus on genes for protease/s. In
Aim 2, we will conduct in silico Molecular Dynamics study to understand MFGE8 conformation changes
required to expose the medin cleavage sites and, informed by gene targets identified in Aim 1, use in silico
protein bioinformatics to select potential protease/s that are structurally predicted to interact with MFGE8 in
appropriate conformation. In Aim 3, we will functionally interrogate the candidate genes/proteins from Aims
1 and 2 by over-expressing or knocking them out individually in reporter endothelial cells and in naïve
endothelial cells, to assess predicted changes in medin generation and confirm their biologic relevance.
Identifying enzymes, proteins and molecular structural determinants of medin generation is a critical step in
understanding and reversing medin pathophysiology that would be useful in addressing vascular aging,
vascular dementia, AD and aortic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
-
批准号:10659843
-
项目类别:
-
资助金额:$54.23万
-
财政年份:2023
-
负责人:Ming Li
-
依托单位:
Understanding vascular aging-related dementia through medin signaling
-
批准号:10901026
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2023
-
负责人:Ming Li
-
依托单位:
Random Field Methods for integrative genomic analysis and high-dimensional risk prediction of congenital heart defects
-
批准号:10905156
-
项目类别:
-
资助金额:$48.76万
-
财政年份:2023
-
负责人:Ming Li
-
依托单位:
Characterization of TMEM251 that causes a new type of severe lysosome storage disease
-
批准号:10502880
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2022
-
负责人:Ming Li
-
依托单位:
Characterization of TMEM251 that causes a new type of severe lysosome storage disease
-
批准号:10705155
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2022
-
负责人:Ming Li
-
依托单位:
Random Field Modelling of genetic and epigenetic association underlying congenital heart defects in the presence of disease heterogeneity
-
批准号:10405321
-
项目类别:
-
资助金额:$5.03万
-
财政年份:2021
-
负责人:Ming Li
-
依托单位:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
-
批准号:10197862
-
项目类别:
-
资助金额:$51.1万
-
财政年份:2020
-
负责人:Ming Li
-
依托单位:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
-
批准号:10415158
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2020
-
负责人:Ming Li
-
依托单位:
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
-
批准号:10610432
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2020
-
负责人:Ming Li
-
依托单位:
Equipment Supplement: Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10387872
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
CORE D
-
批准号:10225397
-
项目类别:
-
资助金额:$13.01万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10472626
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10246417
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10018043
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Undergrad supplement: Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10589309
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Undergrad supplement: Ubiquitin-Dependent Protein Regulation and Quality Control of the Lysosomal Membrane
-
批准号:10809193
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2019
-
负责人:Ming Li
-
依托单位:
Random Field Modelling of Genetic and Epigenetic Association for Congenital Heart Defects in the Presence of Disease Heterogeneity
-
批准号:10078546
-
项目类别:
-
资助金额:$16.84万
-
财政年份:2018
-
负责人:Ming Li
-
依托单位:
Ontogeny and Function of Tumor-associated Macrophages
-
批准号:9753962
-
项目类别:
-
资助金额:$45.21万
-
财政年份:2015
-
负责人:Ming Li
-
依托单位:
Ontogeny and Function of Tumor-associated Macrophages
-
批准号:9103061
-
项目类别:
-
资助金额:$45.65万
-
财政年份:2015
-
负责人:Ming Li
-
依托单位:
Foxo1-dependent Programme in the Control of Regulatory T Cell Function
-
批准号:8777083
-
项目类别:
-
资助金额:$43.94万
-
财政年份:2013
-
负责人:Ming Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: